MedCity News February 5, 2025
Sai Bhamidipati

It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures.

The biopharmaceutical industry faces strict regulations worldwide, making it essential to meet international standards before any new therapy can enter the market. Staying informed about the current and emerging trends in global regulatory management is a must to ensure the successful development and commercialization of biopharmaceutical products.

One of the biggest issues is the existence of different regulatory standards and expectations in various countries and international regions. Each regulatory authority has its own set of guidelines, submission formats, and approval processes. For example, the US Food and Drug Administration (FDA) and the European Medicines Agency...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal
Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity
Ono pays $280M to license Ionis rare disease drug

Share This Article